PortSight Med
Implantable Venous Access Device
Health Tech & Life Sciences
Non Active, May 2022 ceased to operate
Company Overview
Snapshot
Founded in January 2016 by Dean Nachman, PortSight Med operates with 1–10 employees. The company secured one funding round from one investor, InNegev. PortSight Med ceased operations in May 2022.
Business overview
PortSight Med is a Health Tech & Life Sciences company focused on developing medical devices. The company's core technology is a novel, totally implantable venous access device featuring patented optical characteristics. This innovation aims to simplify and enhance the reliability of port location and needle access through non-invasive trans-illumination of the port via the patient's skin. PortSight Med serves the healthcare providers market within the medical technologies, vascular, and non-invasive sectors.
Company Intelligence Q&A
- What is PortSight Med's primary focus?
- PortSight Med is focused on developing a novel, totally implantable venous access device with patented optical characteristics for easy, non-invasive trans-illumination of the port through the patient's skin, aiming to simplify port location and needle access.
- When was PortSight Med founded?
- PortSight Med was founded in January 2016.
- Who is a co-founder of PortSight Med?
- Dean Nachman is a co-founder and CTO of PortSight Med.
- What is the status of PortSight Med?
- PortSight Med is currently non-active and ceased to operate in May 2022.